Results for tag: "Cold Agglutinin Disease Drug"

Cold Agglutinin Disease (CAD) is a rare autoimmune disorder in which the body produces antibodies that attack red blood cells. It is a type of Hematological Disease, which is a disorder of the blood and bone marrow. Treatment for CAD typically involves the use of drugs that suppress the immune system, such as corticosteroids, immunosuppressants, and monoclonal antibodies. These drugs are used to reduce the production of antibodies and reduce the destruction of red blood cells. In some cases, blood transfusions may be necessary to replace lost red blood cells. The Cold Agglutinin Disease Drug market is a small but growing segment of the Hematological Drugs market. It is driven by the increasing prevalence of CAD, as well as the development of new drugs to treat the condition. The market is expected to grow in the coming years, as more drugs become available and the number of CAD patients increases. Some companies in the Cold Agglutinin Disease Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more